Feb 28, 2020 8:59am EST Medexus Expands its US Product Portfolio by Acquiring the Hematology Asset IXINITY®
Feb 18, 2020 6:52pm EST Medexus Pharmaceuticals Reports Revenue of $16.2 Million for the Third Quarter of Fiscal 2020
Nov 29, 2019 5:00pm EST Medexus Pharmaceuticals Reports Operating and Financial Results for the Second Quarter of Fiscal 2020
Oct 22, 2019 9:00am EDT Medexus Pharmaceuticals to Present at the Dawson James Securities 5th Annual Small Cap Growth Conference
Sep 12, 2019 8:30am EDT Medexus Reports Health Quality Ontario Recommends Gliolan® for Public Reimbursement
